Rheumatoid Arthritis Therapeutics Market Sees New Opportunities in Biologic Treatments
November 2, 2026 — The global rheumatoid arthritis therapeutics market is estimated at USD 28.22 billion in 2026 and is projected to reach USD 45.53 billion by 2036, expanding at a compound annual growth rate (CAGR) of 4.9% during the forecast period, according to Fact.MR. The market was valued at approximately USD 26.9 billion in 2025. Growing adoption of advanced biologic treatments,...
0 Reacties 0 aandelen 6 Views 0 voorbeeld